CCNE2 and central nervous system cancer: The progression of IDHmut gliomas from lower grade to grade IV involves multiple CNAs, particularly on chromosome 10q, affecting biologically relevant pathways including: activation of PI3K signaling through loss of PTEN and gain of mTOR, as well as activation of cell cycle signaling through gain of CDK4, CDK6, and cyclinE2.